Login / Sign Up
Cart
 

Screening Results You Can Trust

Newborn screening is one of the world's most successful public health programs; infants are screened for disorders that may be inherited, infectious, or caused by a medical problem of the mother. If these disorders are not detected and treated soon after birth, they may cause mental retardation, severe illness, or premature death. Let the EIAs and RIAs from MP Biomedicals provide the tools you need to detect and properly diagnose life-threatening metabolic disorders in newborns.

  • Manufactured in the US under strict ISO and GMP quality systems
  • Used with Blood Spot samples
  • Simple testing protocols
  • Multiple pack sizes available
  • Convenient option for automation
17α-Hydroxyprogesterone

17α-Hydroxyprogesterone

An indicator of Congenital Adrenal Hyperplasia

Congenital Adrenal Hyperplasia (CAH) occurs from a deficiency of 21-hydroxysteroid dehydrogenase, which is responsible for converting 17OHP to 11-desoxycortisol. Failure to diagnose CAH in newborns may lead to hypotension, ambiguous genitalia, acceleration of skeletal maturation, virilization, adrenal insufficiency and premature development of secondary sex characteristics. Approximately 1 in 10,000 newborns are affected.

EIA  RIA

Galactose

An indicator of Classical Galactosemia

Galactosemia is a hereditary condition that presents as a genetic defect in the conversion of galactose to glucose. Galactosemia is caused by two separate disorders: a galactokinase deficiency or uridine